Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Zepp Health Corporation to Report Second Quarter 2025 Financial Results on August 3, 2025
2025-07-14 19:00
Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform
2025-07-14 15:38
CARsgen Successfully Defends Its GPC3 CAR-T Patent at the EPO
2025-07-14 08:00
Angel Yeast Unveils 2024 Sustainability Report, Showcasing Commitment to Green Practices and Innovation
2025-07-11 15:18
LG Debuts Next-Generation Precision Medical AI
2025-07-10 20:54
Earendil Labs announces initiation of a phase 1 study of a half-life extended novel anti-TL1A antibody
2025-07-10 19:00
Tokyo Lifestyle Co., Ltd. Reports Fiscal Year 2025 Financial Results
2025-07-10 18:00
Vita Therapeutics and I Peace announced a development program to generate iPS-derived differentiated cells for transplant therapy with an initial focus on FSHD (Facioscapulohumeral Muscular Dystrophy) using universal iPS cells
2025-07-10 18:00
NextRise 2025 Held in Seoul, Asia's Leading Innovation Expo Co-hosted by KITA and KDB
2025-07-10 16:38
Zhimeng Biopharma's Next-Generation KCNQ2/3 Potassium Channel Opener Receives Clinical Trial Approval for ALS Phase 2/3 Study
2025-07-10 00:00
GenScript Biotech Earns EcoVadis Silver Medal, Ranking in Top 15% Globally for Sustainability
2025-07-09 20:32
Kazia Therapeutics Reports Early Efficacy Data from First Triple-Negative Breast Cancer Patient Receiving Paxalisib Combination Regimen achieving >50% Reduction in Circulating Tumor Cells in Phase 1b Trial
2025-07-09 20:00
First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418
2025-07-09 11:14
LakeShore Biopharma Announces US$15 Million Private Placement Financing
2025-07-08 19:25
WuXi AppTec Provides Updates on Q2 Share Repurchase/Acquisition Activities
2025-07-08 10:41
Celltrion USA announces U.S. launch of denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo)
2025-07-08 10:08
WuXi AppTec Receives MSCI ESG AAA Leader Rating
2025-07-07 20:08
Coreline Soft and Temple Health to Co-Host Webinar on AI-Driven Lung Cancer Screening and Improving Patient Outcomes
2025-07-07 20:00
The Voices of Persons Affected by Hansen's Disease Move the World: 3rd Global Forum Held in Bali, Indonesia
2025-07-07 19:00
Nuevocor Strengthens Board with Appointment of Thierry Abribat
2025-07-07 13:00
1
28
29
30
31
32
873